14.07.2016 Views

PRIVATE PATENTS AND PUBLIC HEALTH

private-patents-and-public-health

private-patents-and-public-health

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

NGOS ADVOCATE FOR <strong>HEALTH</strong> PRIMACY OVER <strong>PATENTS</strong><br />

Non-governmental organisations (NGOs) also increased their<br />

involvement in the trade and health debates and focussed their attention<br />

on the WTO. In anticipation of the 1999 Seattle WTO ministerial<br />

conference, there was a flurry of activity that strengthened the IP<br />

knowledge base that NGOs had and their ability to mobilise quickly in<br />

relation to the issue.<br />

Fuelled by the “health primacy” debates at the WHA and against the<br />

backdrop of the court case between South Africa and thirty-nine<br />

pharmaceutical companies claiming some of South Africa’s provisions to<br />

increase access to medicines were not compliant with TRIPS, 38 a coalition<br />

of groups consisting of Health Action International (HAI), the Consumer<br />

Project on Technology (CPTech, now Knowledge Ecology International or<br />

KEI), Act Up–Paris, the Health GAP Coalition, Oxfam, and the Access to<br />

Medicines Campaign of Médecins Sans Frontières (MSF) came together.<br />

These groups worked in close collaboration with national treatment<br />

action groups in various countries, notably in Thailand, Brazil, India,<br />

Malaysia, Indonesia, Kenya, South Africa and others.<br />

In March 1999, MSF, HAI and CPTech organised the first meeting on<br />

compulsory licensing of AIDS medicines, held at the UN in Geneva. Later<br />

that year, a larger coalition of NGOs organised a global conference in<br />

Amsterdam on access to medicines. At the Amsterdam conference,<br />

participants called for health to be made a priority at the WTO Seattle<br />

negotiations and demanded a balance between the rights of patent holders<br />

and the rights of citizens in IP rights regulations. These views were shared<br />

by representatives of UNDP, WHO, WTO, members of the governments of<br />

the Netherlands and Thailand, and NGOs attending the Amsterdam<br />

conference. The meeting brought together 350 participants from 50<br />

developing and developed countries, from the private and public sectors. 39<br />

NEGOTIATIONS ON TRIPS <strong>AND</strong> <strong>PUBLIC</strong> <strong>HEALTH</strong> AT THE WTO,<br />

1999–2001<br />

1<br />

ENDING GLOBAL DIVERSITY IN PATENT LAWS: THE TRIPS AGREEMENT<br />

The debate on TRIPS and public health started at the WTO in late 1999<br />

at the ministerial in Seattle. While not on the official agenda, the issue of<br />

public health and access to medicines received attention for a number of<br />

reasons.<br />

First, the European Commission prepared a Common Working Paper<br />

that proposed developing countries be allowed to issue “compulsory<br />

26

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!